Comparative Evaluation of Safety and Efficacy of Glimepiride and Sitagliptin in Combination with Metformin in Patients with Type 2 Diabetes Mellitus: Indian Multicentric Randomized Trial - START Study.

Devarajan, T V; Venkataraman, S; Kandasamy, Narayanan; Oomman, Abraham; Boorugu, Hari Kishan; Karuppiah, S K P; Balat, Dushyant

Devarajan, T V; Venkataraman, S; Kandasamy, Narayanan; Oomman, Abraham; Boorugu, Hari Kishan; Karuppiah, S K P; Balat, Dushyant.

Afiliación

Devarajan TV; Consultant Physician, Apollo First Med Hospitals, Chennai, Tamil Nadu, India.
Venkataraman S; Consultant Physician and Diabetologist, Apollo Hospitals, Chennai, Tamil Nadu, India.
Kandasamy N; Consultant Endocrinologist and Diabetologist, Apollo Hospitals, Chennai, Tamil Nadu, India.
Oomman A; Consultant Cardiologist, Apollo Hospitals, Chennai, Tamil Nadu, India.
Boorugu HK; Consultant Physician, Apollo Hospitals, Hyderabad, Telangana, India.
Karuppiah SKP; Consultant Cardiologist, Apollo Speciality Hospital, Madurai, Tamil Nadu, India.
Balat D; Consultant Cardiologist, Apollo Hospitals International Limited, Ahmedabad, Gujarat, India.

Indian J Endocrinol Metab ; 21(5): 745-750, 2017.

Article en En | MEDLINE | ID: mdl-28989886

Palabras clave

Glimepiride; metformin; modern sulfonylurea; sitagliptin; type 2 diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Indian J Endocrinol Metab Año: 2017 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google